PORT ST. LUCIE, Fla. -- (BUSINESS WIRE) -- The Vaccine & Gene Therapy Institute of Florida (VGTI Florida) hosted a delegation of medical scientists from the Karolinska Institutet for a research symposium titled “Innovative Approaches to Treating the Diseases of Aging”, held on February 5th-6th, 2014. Karolinska Institutet in Stockholm, Sweden, is world renowned for bestowing the annual Nobel Prize in Physiology or Medicine. Over the course of two days, researchers from VGTI Florida and Karolinska University, along with guest speakers from across North America, presented on topics that focus on diseases of aging.
The symposium was one of the first steps that VGTI Florida is taking towards developing the Center for Diseases of Aging (CDA) at their location in Port St. Lucie, FL. The CDA will be a platform for scientists from VGTI Florida to find solutions to health issues in the aging population in collaboration with scientists from Karolinska Institutet and other medical research institutions around the world.
“VGTI Florida was honored to host the medical scientists from Karolinska Institutet in this collaborative symposium. The goal of this research is to develop more effective treatments and thus reduce the personal and economic burdens of diseases of aging,” said Richard Jove, Ph.D., President and Director of VGTI Florida.
Topics at the symposium included Aging and the Immune System, Aging and Inflammation, Personalized and Precision Medicine, Innate and Adaptive Immunity, HIV & Viral Infections, and Global Collaboration in Translational Medicine. Speakers presented their latest research on cancer, infectious diseases, cardiovascular, neurodegenerative and other diseases of aging.
A reception and dinner at VGTI Florida on the 5th allowed the researchers, speakers, and special guests the opportunity to discuss how their collaborative research might have the greatest impact. The keynote speaker at the event was Hans-Gustaf Ljunggren, M.D., Ph.D., Dean of Research at Karolinska Institutet.
“Aging research is becoming a very important research focus at the moment; perhaps one of the most discussed areas of research in all categories, both in the US and in Europe, and in Asia as well,” said Dr. Ljunggren.
This was the second delegation of medical scientists from Karolinska Institutet to visit VGTI Florida, following up on their initial introductory visit in October, 2013 to explore possibilities for research collaboration.
About VGTI Florida:
VGTI Florida is a non-profit biomedical research institute dedicated to understanding the roles of our immune system and our genes in disease, as well as the development of innovative treatments. VGTI Florida is an independent non-profit 501(c)(3) organization located in the Tradition Center for Innovation in Port St. Lucie, Florida. For more information, please visit www.VGTIFL.org. VGTI Florida® and Translating Research into Health® are Registered Trademarks of the Vaccine & Gene Therapy Institute of Florida.